Subscribe
Dreamfinity Ltd / Shutterstock.com
5 December 2024NewsAmericasLiz Hockley

EOFlow ordered to pay rival $452m over insulin patch trade secrets

Jury finds medical device company misappropriated secrets covering Insulet’s Omnipod l Insulet “extremely pleased” with verdict l Federal circuit overturned ban on EOFlow’s product in June.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Big Pharma
Medtronic’s $738m deal with insulin maker at risk
12 October 2023   Insulet has been awarded a preliminary injunction against EOFlow on its insulin patch pump products | Dispute and injunction come ahead of Medtronic’s planned $738m acquisition of EOFlow.
Big Pharma
Federal Circuit overturns ban on EOFlow’s insulin pump patches
18 June 2024   Judge says lower court abused discretion when issuing injunction | Negative impact of potential Medtronic deal on Insulet was “mere conjecture”.


Editor's picks

Americas
Trump’s return sparks calls for pro-patent agenda
5 December 2024

Editor's picks

Americas
Trump’s return sparks calls for pro-patent agenda
5 December 2024
Americas
Comparing life sciences IP in Brazil and the US
28 November 2024
Americas
UPC bans Meril Life Sciences from selling infringing heart valve
19 November 2024
Americas
Amgen set for ‘at-risk’ launch of blockbuster eye drug biosimilar
24 October 2024
Americas
Big Pharma counsel embrace AI but data and legal risks loom
24 October 2024
Asia
President Xi sends message to AIPPI’s World Congress
22 October 2024

More on this story

Big Pharma
Medtronic’s $738m deal with insulin maker at risk
12 October 2023   Insulet has been awarded a preliminary injunction against EOFlow on its insulin patch pump products | Dispute and injunction come ahead of Medtronic’s planned $738m acquisition of EOFlow.
Big Pharma
Federal Circuit overturns ban on EOFlow’s insulin pump patches
18 June 2024   Judge says lower court abused discretion when issuing injunction | Negative impact of potential Medtronic deal on Insulet was “mere conjecture”.

More on this story

Big Pharma
Medtronic’s $738m deal with insulin maker at risk
12 October 2023   Insulet has been awarded a preliminary injunction against EOFlow on its insulin patch pump products | Dispute and injunction come ahead of Medtronic’s planned $738m acquisition of EOFlow.
Big Pharma
Federal Circuit overturns ban on EOFlow’s insulin pump patches
18 June 2024   Judge says lower court abused discretion when issuing injunction | Negative impact of potential Medtronic deal on Insulet was “mere conjecture”.

More features

Fed Circ orders Teva to delist five patents from Orange Book
Sarepta wins $115M in patent dispute over muscular dystrophy drug
Novartis shields eye-drop patent at European Patent Office
CREATES Act unfairly tips the scales to generics
LSPN launches its first-ever US awards to celebrate life sciences leaders
Pharma giants seek closure on COVID-19 vaccine rows
How Inhibrx defended a $450m damages suit
Foley & Lardner adds litigation and transaction expert in New York